Phase 1 Alzheimer's Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Alzheimer s DiseaseBeta-AmyloidProdromal Alzheimer's Disease+2 more
AC Immune SA304 enrolled26 locationsNCT05462106
Recruiting
Phase 1Phase 2
The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease
Mild to moderate Alzheimer's disease
Xuanwu Hospital, Beijing33 enrolled1 locationNCT07457125
Recruiting
Phase 1
A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic Efficacy
MCIAD - Alzheimer's Disease
Eli Radiopharma18 enrolled1 locationNCT07580703
Recruiting
Phase 1
A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
SchizophreniaAlzheimer's Disease Psychosis
Luye Pharma Group Ltd.40 enrolled1 locationNCT07230652
Recruiting
Phase 1
Exploring the Utility of [18F]3F4AP for Demyelination Imaging
Alzheimer's Disease(AD)MCIDemyelinating Disorders+3 more
Yale University105 enrolled1 locationNCT06999434